4 ms·
Part of the issue with biotech is that it costs so much to fail. Companies have to spend massive amounts of money just to find out an idea isn't going to work.
by waterlesscloud 13y ago
Part of the issue with biotech is that it costs so much to fail. Companies have to spend massive amounts of money just to find out an idea isn't going to work.
- refurb 13y agoI don't disagree. For the most part biotech investment outcomes are binary. You either win or you lose (there are some exceptions). And since it typically costs $5-10M just to be able to test your drug in the first human, when biotechs fail, they fail hard.